اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است
ADDERALL 10 از شرکت TEVA WOMENS
New Drug Application (NDA): 011522
Company: TEVA WOMENS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ADDERALL 10 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 2.5MG;2.5MG;2.5MG;2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued |
None |
Yes | No |
ADDERALL 12.5 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 3.125MG;3.125MG;3.125MG;3.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued |
None |
Yes | No |
ADDERALL 15 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 3.75MG;3.75MG;3.75MG;3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued |
None |
Yes | No |
ADDERALL 20 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 5MG;5MG;5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued |
None |
Yes | No |
ADDERALL 30 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 7.5MG;7.5MG;7.5MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued |
None |
Yes | No |
ADDERALL 5 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 1.25MG;1.25MG;1.25MG;1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued |
None |
Yes | No |
ADDERALL 7.5 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | 1.875MG;1.875MG;1.875MG;1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET;ORAL | Discontinued |
None |
Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/19/1960 | ORIG-1 | Approval |
Type 2 New Active Ingredient and Type 4 New Combination |
STANDARD |
|
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
01/04/2017 | SUPPL-43 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/011522s043lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/011522Orig1s043ltr.pdf |
||
10/01/2015 | SUPPL-42 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s042lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/011522Orig1s042ltr.pdf |
||
04/17/2015 | SUPPL-41 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s041lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/011522Orig1s041ltr.pdf |
||
06/07/2007 | SUPPL-40 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011522s040lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/011522s040ltr.pdf |
||
07/26/2006 | SUPPL-37 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011522s034s037,021303s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/011522s034, 037, 021303s013LTR.pdf |
||
07/26/2006 | SUPPL-34 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011522s034s037,021303s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/011522s034, 037, 021303s013LTR.pdf |
||
08/02/2005 | SUPPL-33 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/011522s032,033lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/011522s032,033ltr.pdf |
||
08/02/2005 | SUPPL-32 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/011522s032,033lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/011522s032,033ltr.pdf |
||
11/08/2002 | SUPPL-30 | Manufacturing (CMC)-Formulation |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/11522scf030ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/11-522S030_Adderall.cfm |
|
04/11/2002 | SUPPL-29 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/10/2001 | SUPPL-28 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
07/24/2000 | SUPPL-27 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
08/31/2000 | SUPPL-26 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/15/2000 | SUPPL-25 | Manufacturing (CMC) |
Label is not available on this site. |
||
01/26/2000 | SUPPL-24 | Manufacturing (CMC) |
Label is not available on this site. |
||
09/20/1999 | SUPPL-23 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
11/12/1999 | SUPPL-22 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
05/21/1999 | SUPPL-21 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/23/1999 | SUPPL-20 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/16/1998 | SUPPL-19 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
01/08/1998 | SUPPL-18 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
07/25/1997 | SUPPL-17 | Labeling |
Label is not available on this site. |
||
11/14/1997 | SUPPL-16 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
07/17/1997 | SUPPL-15 | Labeling |
Label is not available on this site. |
||
06/13/1997 | SUPPL-14 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
05/12/1997 | SUPPL-13 | Manufacturing (CMC) |
Label is not available on this site. |
||
01/29/1997 | SUPPL-12 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
07/17/1997 | SUPPL-11 | Labeling |
Label is not available on this site. |
||
02/13/1996 | SUPPL-10 | Manufacturing (CMC)-Formulation |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/11522S010_Adderall.pdf |
|
02/13/1996 | SUPPL-9 | Labeling |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
01/04/2017 | SUPPL-43 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/011522s043lbl.pdf | |
10/01/2015 | SUPPL-42 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s042lbl.pdf | |
04/17/2015 | SUPPL-41 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s041lbl.pdf | |
06/07/2007 | SUPPL-40 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011522s040lbl.pdf | |
07/26/2006 | SUPPL-37 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011522s034s037,021303s013lbl.pdf | |
07/26/2006 | SUPPL-34 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011522s034s037,021303s013lbl.pdf | |
08/02/2005 | SUPPL-33 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/011522s032,033lbl.pdf | |
08/02/2005 | SUPPL-32 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/011522s032,033lbl.pdf |
نظرات کاربران